Beatrice Nardone Selected Research

Beatrice Nardone Research Topics

Disease

7	Melanoma (Melanoma, Malignant) 03/2021 - 01/2017
7	Drug-Related Side Effects and Adverse Reactions 09/2020 - 05/2013
6	Neoplasms (Cancer) 03/2021 - 09/2010
3	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2018 - 11/2009
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2018 - 01/2017
3	Skin Neoplasms (Skin Cancer) 01/2018 - 01/2017
3	Quadriplegia (Spastic Quadriplegia) 01/2016 - 11/2013
2	Infections 01/2022 - 09/2017
2	Pancreatitis 01/2018 - 05/2014
2	Basal Cell Carcinoma (Rodent Ulcer) 01/2018 - 01/2017
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2014 - 11/2013
2	Exanthema (Rash) 08/2013 - 09/2010
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	COVID-19 01/2022
1	Acne Vulgaris 07/2019
1	Hyperkalemia 07/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2018
1	Hypertension (High Blood Pressure) 12/2017
1	Type 2 Diabetes Mellitus (MODY) 12/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2017
1	Osteoporosis 12/2017
1	Pemphigus (Pemphigus Vulgaris) 12/2017
1	Erectile Dysfunction 01/2017
1	Vitiligo 12/2016
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2016
1	Alopecia (Baldness) 06/2015
1	Fibrosis (Cirrhosis) 05/2014
1	Nephrogenic Fibrosing Dermopathy 02/2014
1	Anaphylaxis (Anaphylactic Shock) 01/2014
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2014
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2013
1	Multiple Myeloma 08/2013
1	Erythema 06/2012
1	Inflammation (Inflammations) 09/2010
1	Hutchinson's Melanotic Freckle (Lentigo Maligna) 11/2008
1	Hyperhidrosis 07/2008
1	Contact Dermatitis (Eczema, Contact) 07/2008

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2018 - 05/2013
4	tyramine-deoxysorbitolIBA 01/2016 - 11/2013
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 10/2018
2	Biological ProductsIBA 06/2018 - 09/2017
2	Tumor Necrosis Factor InhibitorsIBA 06/2018 - 01/2018
2	Angiotensin Receptor AntagonistsIBA 01/2018 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2017 - 11/2009
2	Finasteride (Propecia)FDA LinkGeneric 01/2017 - 06/2015
2	Contrast MediaIBA 02/2014 - 01/2014
2	GadoliniumIBA 02/2014 - 01/2014
1	dupilumabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 09/2020
1	Spironolactone (Aldactone)FDA LinkGeneric 07/2019
1	PotassiumIBA 07/2019
1	Natalizumab (Tysabri)FDA Link 01/2019
1	secukinumabIBA 10/2018
1	Interleukin-17 (Interleukin 17)IBA 10/2018
1	ixekizumabIBA 10/2018
1	InterleukinsIBA 06/2018
1	Interleukin-12 (IL 12)IBA 06/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2018
1	Phosphodiesterase 4 InhibitorsIBA 06/2018
1	Methotrexate (Mexate)FDA LinkGeneric 06/2018
1	Janus Kinase 1IBA 06/2018
1	blinatumomabIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	Coenzyme A (CoA)IBA 01/2018
1	Phosphodiesterase 5 InhibitorsIBA 01/2018
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017
1	ThiazidesIBA 01/2017
1	Dutasteride (Avodart)FDA Link 01/2017
1	romidepsin (FK228)FDA Link 06/2016
1	Histone Deacetylase InhibitorsIBA 06/2016
1	Brentuximab VedotinIBA 05/2014
1	CollagenIBA 05/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2013
1	Lenalidomide (CC 5013)FDA Link 08/2013
1	Sorafenib (BAY 43-9006)FDA Link 11/2012
1	Sunitinib (Sutent)FDA Link 11/2012
1	salicylhydroxamic acid (SHAM)IBA 06/2012
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2010
1	Antineoplastic Agents (Antineoplastics)IBA 09/2010
1	ErbB Receptors (EGF Receptor)IBA 09/2010
1	Biomarkers (Surrogate Marker)IBA 09/2010
1	Panitumumab (Vectibix)FDA Link 09/2010
1	Lapatinib (GW572016)FDA Link 09/2010
1	Cetuximab (Erbitux)FDA Link 09/2010
1	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 11/2009
1	Imiquimod (Aldara)FDA LinkGeneric 11/2008
1	aluminum sesquichlorohydrateIBA 07/2008
1	Irritants (Vesicants)IBA 07/2008

Therapy/Procedure

4	Therapeutics 01/2022 - 09/2010
2	Body Piercing (Piercing, Body) 01/2015 - 01/2014
2	Self-Help Devices (Assistive Technology) 01/2015 - 11/2013
1	Immunotherapy 03/2021